companydata.dkChosa ApS: Financial statements 2025
CVR: 43134477
Chosa ApS (CVR 43134477) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity amounted to DKK 5,175,030. The solvency ratio was 38.5%.
- Gross Profit
- -2,136,143 kr.
- Profit/Loss
- -2,632,024 kr.
- Equity
- 5,175,030 kr.
- Total Assets
- 13,427,118 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -2.1 mio. | -2.6 mio. | 5.2 mio. | 0 |
| 2024 | - | -1.1 mio. | -3.6 mio. | 7.5 mio. | 1 |
| 2023 | - | -1.5 mio. | -2.1 mio. | 9 mio. | 0 |
Find more companies like Chosa ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of November 25, 2025, Neil Goldsmith has stepped down as director of Chosa ApS.
Chosa ApS has published its annual report for 2024. Gross profit came to DKK -1,130,610, and the net result was DKK -3,586,839.
About Chosa ApS
Chosa ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2022. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Claus Frisenberg Pedersen and Peter Buhl. The company is owned by Chosa Oncology AB. In 2025, the company reported a gross profit of DKK -2,136,143 and a net result of DKK -2,632,024 compared with DKK -3,586,839 the year before. Equity amounted to DKK 5,175,030.